Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Kristen Detweiler Short, RN, CNP, Joseph Mikhael, MD, Angela Dispenzieri, MD, Morie Gertz, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Martha Lacy, MD

Blood (2010) 116 (21): 1965.

https://doi.org/10.1182/blood.V116.21.1965.1965

Published: 2010

Journal Articles

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Shirshendu Sinha, MBBS, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis Buadi, MD, David Dingli, MD, Ph.D., Ivana Micallef, MD, William Hogan, MBBCh, Dennis Gastineau, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2010) 116 (21): 2253.

https://doi.org/10.1182/blood.V116.21.2253.2253

Published: 2010

Journal Articles

Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma.

Blood (2009) 114 (22): 3884.

https://doi.org/10.1182/blood.V114.22.3884.3884

Published: 2009

Journal Articles

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Francis Buadi, MD, Martha Q. Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, Suzanne Hayman, MD, Kristen E Detweiler Short, R.N., C.N.P., David Dingli, M.D., PhD., Steven R. Zeldenrust, M.D., Ph.D., Philip R. Greipp, MD, John A. Lust, MD, PhD, Stephen J. Russell, MD, PhD, Robert Kyle, M.D., Vincent Rajkumar, MD, Morie A Gertz, MD

Blood (2009) 114 (22): 4953.

https://doi.org/10.1182/blood.V114.22.4953.4953

Published: 2009

Journal Articles

Induced Resistance to Bortezomib in Preclinical Model of Waldenstrom Macroglobulinemia Is Associated with Bcl-2 Upregulation.

Kasyapa Chitta, Ph.D., Jean-Gabriel Coignet, Sakina Sojar, Pushpankur Ghoshal, PhD, Kiersten M. Miles, Leighton Stein, Morton Coleman, MD, Richard R. Furman, MD, Craig Hofmeister, MD, Suzanne Hayman, MD, Kelvin P. Lee, MD, Asher A. Chanan-Khan, MD

Blood (2009) 114 (22): 4919.

https://doi.org/10.1182/blood.V114.22.4919.4919

Published: 2009

Journal Articles

Analysis of the Immunoglobulin Heavy and Light Chain Gene Expression and Mutations in POEMS Patients.

Bharathi Aravamudan, Ph.D., Caili Tong, Martha Q. Lacy, MD, Suzanne Hayman, MD, Francis Buadi, MD, Morie A Gertz, MD, Shaji Kumar, Stephen J. Russell, MD, PhD, Angela Dispenzieri, MD

Blood (2009) 114 (22): 4986.

https://doi.org/10.1182/blood.V114.22.4986.4986

Published: 2009

Journal Articles

Outcomes with High Dose Therapy and Peripheral Blood Stem Cell Transplantation for Light Chain (AL) Amyloidosis with Cardiac Involvement.

Sumit Madan, M.D., Shaji Kumar, M.D., Angela Dispenzieri, MD, Martha Q. Lacy, MD, Suzanne Hayman, MD, Francis Buadi, MD, David Dingli, M.D., PhD., Morie A Gertz, MD

Blood (2009) 114 (22): 534.

https://doi.org/10.1182/blood.V114.22.534.534

Published: 2009

Journal Articles

Thalidomide Based Induction Chemotherapy Prior to Stem Cell Transplantation in Myeloma Is Associated with Decreased Response to Retreatment with Thalidomide at First Relapse Post Transplant.

Lijo Simpson, MBBS, Morie Gertz, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis Buadi, MD, Vincent S. Rajkumar, MBBS, Shaji Kumar

Blood (2007) 110 (11): 3607.

https://doi.org/10.1182/blood.V110.11.3607.3607

Published: 2007

Journal Articles

Prognostic Value of Serum Lactate Dehydrogenase (LDH) in Patients with Primary Systemic Amyloidosis Undergoing Stem Cell Transplantation.

Shaji Kumar, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis K. Buadi, MD, David Dingli, MD, Mark R. Litzow, MD, Morie A. Gertz, MD

Blood (2007) 110 (11): 2871.

https://doi.org/10.1182/blood.V110.11.2871.2871

Published: 2007

Journal Articles

Myeloma International Staging System Retains Its Prognostic Value at Disease Relapse.

Rajanshu Verma, MD, Shaji Kumar, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Morie A. Gertz, MD

Blood (2007) 110 (11): 1474.

https://doi.org/10.1182/blood.V110.11.1474.1474

Published: 2007

Journal Articles

Increased Cytotoxic T-Cell Infiltrates in the Bone Marrow Is an Independent Adverse Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.

Grzegorz S. Nowakowski, MD, Chin-Yang Li, MD, David Dingli, MD, PhD, Shaji Kumar, MD, Morie A. Gertz, MD, Martha Q. Lacy, MD, John A. Last, MD, Angela Dispenzieri, MD, Philip R. Greipp, MD, Steven Zeldenrust, MD, PhD, Francis Buadi, MD, Suzanne Hayman, MD, Robert A. Kyle, MD, Vincent S. Rajkumar, MD

Blood (2007) 110 (11): 1492.

https://doi.org/10.1182/blood.V110.11.1492.1492

Published: 2007

Journal Articles

14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH).

Alan H. Bryce, MD, Rhett Ketterling, MD, Morie Gertz, MD, Steve Zeldenrust, MD, Martha Lacy, MD, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Phillip Greipp, MD, John Lust, MD, Vincent Rajkumar, MD, Rafael Fonseca, MD, David Dingli, MD, Stephen Russell, MD, Robert Kyle, MD, Angela Dispenzieri, MD

Blood (2007) 110 (11): 2477.

https://doi.org/10.1182/blood.V110.11.2477.2477

Published: 2007

Journal Articles

A Phase II Study of Alemtuzumab in the Treatment of Plasma Cell Disorders.

Lijo Simpson, MBBS, Shaji Kumar, MBBS, Jacob Allred, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Steven Zeldenrust, MD, S. Vincent Rajkumar, MBBS, John A. Lust, MD, Philip R. Greipp, MD, Morie Abraham Gertz, MD, Thomas E. Witzig, MD

Blood (2006) 108 (11): 5126.

https://doi.org/10.1182/blood.V108.11.5126.5126

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Reduced Renal Function: A Matched Set Comparison.

Shaji Kumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Nelson Leung, MD, Vincent Rajkumar, MD, Steven Zeldenrust, MD, John Lust, MD, Philip Greipp, MD, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2006) 108 (11): 3091.

https://doi.org/10.1182/blood.V108.11.3091.3091

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation Provides Additional Cytoreduction Following Induction Therapy in Multiple Myeloma.

Shaji Kumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, S. Vincent Rajkumar, MD, Steven Zeldenrust, MD, John A. Lust, MD, Philip R. Greipp, MD, Robert Kyle, MD, Morie Gertz, MD

Blood (2006) 108 (11): 3099.

https://doi.org/10.1182/blood.V108.11.3099.3099

Published: 2006

Journal Articles

Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma.

Suzanne Hayman, MD, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Rafael Fonseca, MD, Susan Geyer, PhD, Shaji Kumar, MD, Steven Zeldenrust, MD, Stephen Russell, MD, PhD, John Lust, MD, PhD, Robert Kyle, MD, Philip Greipp, MD, Thomas Witzig, MD, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 3568.

https://doi.org/10.1182/blood.V108.11.3568.3568

Published: 2006

Journal Articles

Lenalidomide Plus Dexamethasone (Rev/Dex) in Newly Diagnosed Myeloma: Response to Therapy, Time to Progression, and Survival.

Martha Lacy, MD, Morie Gertz, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Susan Geyer, PhD, Steven Zeldenrust, MD, Shaji Kumar, MD, Philip Greipp, MD, Rafael Fonseca, MD, John Lust, MD, Stephen Russell, MD, PhD, Robert Kyle, MD, Thomas Witzig, MD, Leif Bergsagel, MD, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 798.

https://doi.org/10.1182/blood.V108.11.798.798

Published: 2006

Journal Articles

Combination Therapy with Lenalidomide Plus Dexamethasone (Rev/Dex) for Newly Diagnosed Myeloma.

S. Vincent Rajkumar, MD, Suzanne Hayman, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Susan M. Geyer, PhD, Brian Kabat, Steven R. Zeldenrust, MD, PhD, Shaji Kumar, MD, Philip R. Greipp, MD, Rafael Fonseca, MD, John A. Lust, MD, PhD, Stephen J. Russell, MD, PhD, Robert A. Kyle, MD, Thomas E. Witzig, MD, Morie A. Gertz, MD

Blood (2005) 106 (11): 781.

https://doi.org/10.1182/blood.V106.11.781.781

Published: 2005

Journal Articles

Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Transplanted for Multiple Myeloma.

David Dingli, MD, PhD, Grzegorz S. Nowakowski, MD, Angela Dispenzieri, MD, Martha Q. Lacy, MD, Suzanne Hayman, MD, Mark R. Litzow, MD, Dennis A. Gastineau, MD, Morie A. Gertz, MD

Blood (2005) 106 (11): 1165.

https://doi.org/10.1182/blood.V106.11.1165.1165

Published: 2005

Journal Articles

Time Interval from Last Chemotherapy to Stem Cell Collection Correlates with Peripheral Blood Absolute Lymphocyte Count at Apheresis and Survival Post-Autologous Stem Cell Transplantation in Non-Hodgkin’s Lymphoma.

Shernan G. Holtan, MD, Luis F. Porrata, MD, David J. Inwards, MD, Stephen A. Ansell, MD, Ivana N.M. Micallef, MD, Mark R. Litzow, MD, Morie A. Gertz, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Dennis A. Gastineau, MD, Ayalew Tefferi, MD, Michelle Elliott, MD, William J. Hogan, MD, Suzanne Hayman, MD, Svetomir N. Markovic, MD

Blood (2004) 104 (11): 2927.

https://doi.org/10.1182/blood.V104.11.2927.2927

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma.

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Induced Resistance to Bortezomib in Preclinical Model of Waldenstrom Macroglobulinemia Is Associated with Bcl-2 Upregulation.

Analysis of the Immunoglobulin Heavy and Light Chain Gene Expression and Mutations in POEMS Patients.

Outcomes with High Dose Therapy and Peripheral Blood Stem Cell Transplantation for Light Chain (AL) Amyloidosis with Cardiac Involvement.

Thalidomide Based Induction Chemotherapy Prior to Stem Cell Transplantation in Myeloma Is Associated with Decreased Response to Retreatment with Thalidomide at First Relapse Post Transplant.

Prognostic Value of Serum Lactate Dehydrogenase (LDH) in Patients with Primary Systemic Amyloidosis Undergoing Stem Cell Transplantation.

Myeloma International Staging System Retains Its Prognostic Value at Disease Relapse.

Increased Cytotoxic T-Cell Infiltrates in the Bone Marrow Is an Independent Adverse Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.

14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH).

A Phase II Study of Alemtuzumab in the Treatment of Plasma Cell Disorders.

Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Reduced Renal Function: A Matched Set Comparison.

Autologous Stem Cell Transplantation Provides Additional Cytoreduction Following Induction Therapy in Multiple Myeloma.

Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma.

Lenalidomide Plus Dexamethasone (Rev/Dex) in Newly Diagnosed Myeloma: Response to Therapy, Time to Progression, and Survival.

Combination Therapy with Lenalidomide Plus Dexamethasone (Rev/Dex) for Newly Diagnosed Myeloma.

Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Transplanted for Multiple Myeloma.

Time Interval from Last Chemotherapy to Stem Cell Collection Correlates with Peripheral Blood Absolute Lymphocyte Count at Apheresis and Survival Post-Autologous Stem Cell Transplantation in Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only